We serve Chemical Name:Nitromide CAS:121-81-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Nitromide
CAS.NO:121-81-3
Synonyms:Benzamide,3,5-dinitro;Unistat;MFCD00007985;3,5-dinitro-benzoic acid amide;EINECS 204-499-8;component of Tristat;Nitroamide;component of Unistat-3;Tristat;3,5-Dinitro-benzoesaeure-amid;nitromide;unistat-3
Molecular Formula:C7H5N3O5
Molecular Weight:211.13200
HS Code:2924299090
Physical and Chemical Properties:
Melting point:183-185 °C(lit.)
Boiling point:314.5ºC at 760mmHg
Density:1.601g/cm3
Index of Refraction:1.653
PSA:134.73000
Exact Mass:211.02300
LogP:2.34860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Benzamide,3,5-dinitro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,unistat-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 204-499-8 Use and application,Tristat technical grade,usp/ep/jp grade.
Related News: As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. Nitromide manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Nitromide supplier For this study, researchers purchased 231 different cosmetics products in the United States and Canada and tested them for fluorine, Bruton said. Nitromide vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Nitromide factory As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters.
